The Discounted Cash Flow (DCF) valuation of Shanghai Kaibao Pharmaceutical Co Ltd (300039.SZ) is 3.81 CNY. With the latest stock price at 6.15 CNY, the upside of Shanghai Kaibao Pharmaceutical Co Ltd based on DCF is -38.0%.
Based on the latest price of 6.15 CNY and our DCF valuation, Shanghai Kaibao Pharmaceutical Co Ltd (300039.SZ) is a sell. selling 300039.SZ stocks now will result in a potential gain of 38.0%.
| Range | Selected | |
| WACC / Discount Rate | 8.4% - 11.0% | 9.7% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 3.17 - 4.98 | 3.81 |
| Upside | -48.4% - -19.0% | -38.0% |